热门资讯> 正文
Aura Biosciences报告第一季度业绩
2024-05-10 00:18
- Aura Biosciences press release (NASDAQ:AURA): Q1 net loss was $19.7 million.
- As of March 31, 2024, Aura had cash and cash equivalents and marketable securities totaling $202.9 million.
- The company believes its current cash and cash equivalents and marketable securities are sufficient to fund its operations into the second half of 2026.
More on Aura Biosciences
- Seeking Alpha’s Quant Rating on Aura Biosciences
- Historical earnings data for Aura Biosciences
- Financial information for Aura Biosciences
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。